Add to My Stocks
$0.95 $0.04 (4.04%) RNUGF stock closing price Sep 19, 2018 (Closing)

For analyzing any company like RENEURON GP PLC from an investment perspective, its important to check the cash flow statement. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For RENEURON GP PLC profits one has to check the income statement and for RENEURON GP PLC debt one has to check the balance sheet. RENEURON GP PLC had cash and cash equivalents of $22.78M at beginning of the year and $36.76M at year end for 2017. RENEURON GP PLC cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. RENEURON GP PLC had an outflow of $-16.51M from operating activities, $30.52M inflow due to financing activities, and $-0.01M outflow due to investing activities for 2017.

View details of RENEURON GP PLC cash flows for latest & last 10 financial years
show more
Fiscal year is Apr - Mar20172016
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow--
Net Increase (Decrease) in Assets Liabilities3.1M-
Cash From (used in) Discontinued Operations--
Other Adjustments Net3.9M-
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.69M-0.44M
Acquisition Disposition of Subsidiaires--
Increase (Decrease) in Investments--
Other Cash Inflow (Outflow) from Investment Activities--
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares-103.24M
Issuance (Repayment) of Debt Securities--
Increase (Decrease) in Bank & Other Borrowings30.52M-72.82M
Payment of Dividends & Other Cash Distributions--
Other Cash from (used by) Financing Activities--4.91M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash--
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year22.78M18.67M
Cash & Equivalents at Year End36.76M26.28M
All figures in USD. M: Millions of USD, B: Billions of USD.

RENEURON GP PLC stock comparison chart provides an easy way to compare the stock price with peers along with details of RENEURON GP PLC stock price history.
The statement of cash flows can be categorized into three main sections:

  • RENEURON GP PLC had a Net Change in Cash and Cash Equivalents of $13.98M for the latest year 2017. If a firm is able to grow its cash, it is considered to be a positive signal and could lead to a jump in the RENEURON GP PLC stock price, albeit too much cash on hand can imply the company has no or limited avenues for growth in which to invest this cash.
  • Cash Flow from operating activities: RENEURON GP PLC reported a negative operating cash flow of $-16.51M for 2017 and has seen an increase from the previous year. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-0.01M for RNUGF stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. RENEURON GP PLC earned $30.52M from financing activities, in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For RENEURON GP PLC Cash Flow

Annual Cash Flow Statements For RENEURON GP PLC Peers

AIT THERAPEUTIC cash flow, Biomerica cash flow, IsoRay cash flow, Kitov Pharma cash flow